世界の皮下薬物投与装置市場予測 2022年-2028年

【英語タイトル】Global Subcutaneous Medicine Delivery Devices Market Growth 2022-2028

LP Informationが出版した調査資料(LPI22SM18343)・商品コード:LPI22SM18343
・発行会社(調査会社):LP Information
・発行日:2022年9月
・ページ数:118
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

世界経済が回復するにつれて、2021年の皮下薬物投与装置の成長は前年から大幅に変化します。LPインフォメーション社の最新の調査によると、世界の皮下薬物投与装置市場規模は、2021年のxxxドルから2022年にはxxxドルに達し、2021年~2022年間にxxx%の変化が予想されます。2028年には世界の皮下薬物投与装置市場規模がxxxドルまで成長し、分析期間中にxxx%のCAGRを記録すると予想されます。
アメリカの皮下薬物投与装置市場は2021年にxxxドルの市場規模が見込まれ、分析期間中は約xxx%のCAGRで成長すると予測されます。中国は世界の皮下薬物投与装置市場のxxx%のシェアを占め、2028年までにxxxドルに達すると展望されます。ヨーロッパの皮下薬物投与装置の状況については、ドイツが2028年までにxxxドルに達し、分析期間にわたってCAGRがxxx%になると予測されます。アジア太平洋地域では、日本と韓国の成長率が、今後5年間でそれぞれxxx%とxxx%になると展望されます。

世界の主要な皮下薬物投与装置プレーヤーとして、Boehringer Ingelheim、 Eli Lily、 Galaxo、 HMD pharmaceuticals、 Merck、 Novartis、 Novo Nordisk、 Pfizer、 Sanofi、 Teva Pharmaceutical、 Zogenix、 BD、 Insulet Corporation、 Enable Injections、 West Pharmaceutical Services、 Ypsomed AG、 Elcam Medical、 Amgen、 Wilhelm Haselmeierなどをカバーしています。売上の面では、世界最大の2社が2021年に約xxx%市場シェアを占めています。

当レポートでは、製品タイプ、アプリケーション(用途)、主要メーカー、主要地域および国ごとの皮下薬物投与装置市場の包括的な概要、市場シェア、および成長機会を掲載します。

タイプ別のセグメンテーション:2017年~2022年までの内訳データと2028年まで予測データ
埋め込み式皮下薬物投与装置、注射式皮下薬物投与装置

アプリケーション(用途)別のセグメンテーション:2017年~2022年までの内訳データと2028年まで予測データ
病院、診療所、その他

当レポートは次の地域と国の市場規模データを掲載します。
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東/アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

また、当レポートは市場の競争状況と主要メーカーの詳細な分析を掲載します。
Boehringer Ingelheim、 Eli Lily、 Galaxo、 HMD pharmaceuticals、 Merck、 Novartis、 Novo Nordisk、 Pfizer、 Sanofi、 Teva Pharmaceutical、 Zogenix、 BD、 Insulet Corporation、 Enable Injections、 West Pharmaceutical Services、 Ypsomed AG、 Elcam Medical、 Amgen、 Wilhelm Haselmeier

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:皮下薬物投与装置の年間販売量2017-2028、地域別現状・将来分析
・皮下薬物投与装置のタイプ別セグメント:埋め込み式皮下薬物投与装置、注射式皮下薬物投与装置
・皮下薬物投与装置のタイプ別販売量:2017-2022年の販売量、売上、市場シェア、販売価格
・皮下薬物投与装置の用途別セグメント:病院、診療所、その他
・皮下薬物投与装置の用途別販売量:2017-2022年の販売量、売上、市場シェア、販売価格

企業別世界の皮下薬物投与装置市場
・企業別のグローバル皮下薬物投与装置市場データ:2020-2022年の年間販売量、市場シェア
・企業別の皮下薬物投与装置の年間売上:2020-2022年の売上、市場シェア
・企業別の皮下薬物投与装置販売価格
・主要企業の皮下薬物投与装置生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

皮下薬物投与装置の地域別レビュー
・地域別の皮下薬物投与装置市場規模2017-2022:年間販売量、売上
・主要国別の皮下薬物投与装置市場規模2017-2022:年間販売量、売上
・南北アメリカの皮下薬物投与装置販売の成長
・アジア太平洋の皮下薬物投与装置販売の成長
・ヨーロッパの皮下薬物投与装置販売の成長
・中東・アフリカの皮下薬物投与装置販売の成長

南北アメリカ市場
・南北アメリカの国別の皮下薬物投与装置販売量、売上(2017-2022)
・南北アメリカの皮下薬物投与装置の種類別販売量
・南北アメリカの皮下薬物投与装置の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の皮下薬物投与装置販売量、売上(2017-2022)
・アジア太平洋の皮下薬物投与装置の種類別販売量
・アジア太平洋の皮下薬物投与装置の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の皮下薬物投与装置販売量、売上(2017-2022)
・ヨーロッパの皮下薬物投与装置の種類別販売量
・ヨーロッパの皮下薬物投与装置の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の皮下薬物投与装置販売量、売上(2017-2022)
・中東・アフリカの皮下薬物投与装置の種類別販売量
・中東・アフリカの皮下薬物投与装置の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・皮下薬物投与装置の製造コスト構造分析
・皮下薬物投与装置の製造プロセス分析
・皮下薬物投与装置の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・皮下薬物投与装置の主要なグローバル販売業者
・皮下薬物投与装置の主要なグローバル顧客

地域別の皮下薬物投与装置市場予測レビュー
・地域別の皮下薬物投与装置市場規模予測(2023-2028)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・皮下薬物投与装置のタイプ別市場規模予測
・皮下薬物投与装置の用途別市場規模予測

主要企業分析
Boehringer Ingelheim、 Eli Lily、 Galaxo、 HMD pharmaceuticals、 Merck、 Novartis、 Novo Nordisk、 Pfizer、 Sanofi、 Teva Pharmaceutical、 Zogenix、 BD、 Insulet Corporation、 Enable Injections、 West Pharmaceutical Services、 Ypsomed AG、 Elcam Medical、 Amgen、 Wilhelm Haselmeier
・企業情報
・皮下薬物投与装置製品
・皮下薬物投与装置販売量、売上、価格、粗利益(2020-2022)
・主要ビジネス概要
・最新動向

調査結果および結論

As the global economy mends, the 2021 growth of Subcutaneous Medicine Delivery Devices will have significant change from previous year. According to our (LP Information) latest study, the global Subcutaneous Medicine Delivery Devices market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Subcutaneous Medicine Delivery Devices market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Subcutaneous Medicine Delivery Devices market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Subcutaneous Medicine Delivery Devices market, reaching US$ million by the year 2028. As for the Europe Subcutaneous Medicine Delivery Devices landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Subcutaneous Medicine Delivery Devices players cover Boehringer Ingelheim, Eli Lily, Galaxo, and HMD pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Subcutaneous Medicine Delivery Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Implantable Subcutaneous Medicine Delivery Device
Injection Type Subcutaneous Medicine Delivery Device
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Boehringer Ingelheim
Eli Lily
Galaxo
HMD pharmaceuticals
Merck
Novartis
Novo Nordisk
Pfizer
Sanofi
Teva Pharmaceutical
Zogenix
BD
Insulet Corporation
Enable Injections
West Pharmaceutical Services
Ypsomed AG
Elcam Medical
Amgen
Wilhelm Haselmeier

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Subcutaneous Medicine Delivery Devices Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Subcutaneous Medicine Delivery Devices by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Subcutaneous Medicine Delivery Devices by Country/Region, 2017, 2022 & 2028
2.2 Subcutaneous Medicine Delivery Devices Segment by Type
2.2.1 Implantable Subcutaneous Medicine Delivery Device
2.2.2 Injection Type Subcutaneous Medicine Delivery Device
2.3 Subcutaneous Medicine Delivery Devices Sales by Type
2.3.1 Global Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2017-2022)
2.3.2 Global Subcutaneous Medicine Delivery Devices Revenue and Market Share by Type (2017-2022)
2.3.3 Global Subcutaneous Medicine Delivery Devices Sale Price by Type (2017-2022)
2.4 Subcutaneous Medicine Delivery Devices Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Subcutaneous Medicine Delivery Devices Sales by Application
2.5.1 Global Subcutaneous Medicine Delivery Devices Sale Market Share by Application (2017-2022)
2.5.2 Global Subcutaneous Medicine Delivery Devices Revenue and Market Share by Application (2017-2022)
2.5.3 Global Subcutaneous Medicine Delivery Devices Sale Price by Application (2017-2022)
3 Global Subcutaneous Medicine Delivery Devices by Company
3.1 Global Subcutaneous Medicine Delivery Devices Breakdown Data by Company
3.1.1 Global Subcutaneous Medicine Delivery Devices Annual Sales by Company (2020-2022)
3.1.2 Global Subcutaneous Medicine Delivery Devices Sales Market Share by Company (2020-2022)
3.2 Global Subcutaneous Medicine Delivery Devices Annual Revenue by Company (2020-2022)
3.2.1 Global Subcutaneous Medicine Delivery Devices Revenue by Company (2020-2022)
3.2.2 Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Company (2020-2022)
3.3 Global Subcutaneous Medicine Delivery Devices Sale Price by Company
3.4 Key Manufacturers Subcutaneous Medicine Delivery Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Subcutaneous Medicine Delivery Devices Product Location Distribution
3.4.2 Players Subcutaneous Medicine Delivery Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Subcutaneous Medicine Delivery Devices by Geographic Region
4.1 World Historic Subcutaneous Medicine Delivery Devices Market Size by Geographic Region (2017-2022)
4.1.1 Global Subcutaneous Medicine Delivery Devices Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Subcutaneous Medicine Delivery Devices Annual Revenue by Geographic Region
4.2 World Historic Subcutaneous Medicine Delivery Devices Market Size by Country/Region (2017-2022)
4.2.1 Global Subcutaneous Medicine Delivery Devices Annual Sales by Country/Region (2017-2022)
4.2.2 Global Subcutaneous Medicine Delivery Devices Annual Revenue by Country/Region
4.3 Americas Subcutaneous Medicine Delivery Devices Sales Growth
4.4 APAC Subcutaneous Medicine Delivery Devices Sales Growth
4.5 Europe Subcutaneous Medicine Delivery Devices Sales Growth
4.6 Middle East & Africa Subcutaneous Medicine Delivery Devices Sales Growth
5 Americas
5.1 Americas Subcutaneous Medicine Delivery Devices Sales by Country
5.1.1 Americas Subcutaneous Medicine Delivery Devices Sales by Country (2017-2022)
5.1.2 Americas Subcutaneous Medicine Delivery Devices Revenue by Country (2017-2022)
5.2 Americas Subcutaneous Medicine Delivery Devices Sales by Type
5.3 Americas Subcutaneous Medicine Delivery Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Subcutaneous Medicine Delivery Devices Sales by Region
6.1.1 APAC Subcutaneous Medicine Delivery Devices Sales by Region (2017-2022)
6.1.2 APAC Subcutaneous Medicine Delivery Devices Revenue by Region (2017-2022)
6.2 APAC Subcutaneous Medicine Delivery Devices Sales by Type
6.3 APAC Subcutaneous Medicine Delivery Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Subcutaneous Medicine Delivery Devices by Country
7.1.1 Europe Subcutaneous Medicine Delivery Devices Sales by Country (2017-2022)
7.1.2 Europe Subcutaneous Medicine Delivery Devices Revenue by Country (2017-2022)
7.2 Europe Subcutaneous Medicine Delivery Devices Sales by Type
7.3 Europe Subcutaneous Medicine Delivery Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Subcutaneous Medicine Delivery Devices by Country
8.1.1 Middle East & Africa Subcutaneous Medicine Delivery Devices Sales by Country (2017-2022)
8.1.2 Middle East & Africa Subcutaneous Medicine Delivery Devices Revenue by Country (2017-2022)
8.2 Middle East & Africa Subcutaneous Medicine Delivery Devices Sales by Type
8.3 Middle East & Africa Subcutaneous Medicine Delivery Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Subcutaneous Medicine Delivery Devices
10.3 Manufacturing Process Analysis of Subcutaneous Medicine Delivery Devices
10.4 Industry Chain Structure of Subcutaneous Medicine Delivery Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Subcutaneous Medicine Delivery Devices Distributors
11.3 Subcutaneous Medicine Delivery Devices Customer
12 World Forecast Review for Subcutaneous Medicine Delivery Devices by Geographic Region
12.1 Global Subcutaneous Medicine Delivery Devices Market Size Forecast by Region
12.1.1 Global Subcutaneous Medicine Delivery Devices Forecast by Region (2023-2028)
12.1.2 Global Subcutaneous Medicine Delivery Devices Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Subcutaneous Medicine Delivery Devices Forecast by Type
12.7 Global Subcutaneous Medicine Delivery Devices Forecast by Application
13 Key Players Analysis
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Product Offered
13.1.3 Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 Eli Lily
13.2.1 Eli Lily Company Information
13.2.2 Eli Lily Subcutaneous Medicine Delivery Devices Product Offered
13.2.3 Eli Lily Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Eli Lily Main Business Overview
13.2.5 Eli Lily Latest Developments
13.3 Galaxo
13.3.1 Galaxo Company Information
13.3.2 Galaxo Subcutaneous Medicine Delivery Devices Product Offered
13.3.3 Galaxo Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Galaxo Main Business Overview
13.3.5 Galaxo Latest Developments
13.4 HMD pharmaceuticals
13.4.1 HMD pharmaceuticals Company Information
13.4.2 HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Product Offered
13.4.3 HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 HMD pharmaceuticals Main Business Overview
13.4.5 HMD pharmaceuticals Latest Developments
13.5 Merck
13.5.1 Merck Company Information
13.5.2 Merck Subcutaneous Medicine Delivery Devices Product Offered
13.5.3 Merck Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Merck Main Business Overview
13.5.5 Merck Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Subcutaneous Medicine Delivery Devices Product Offered
13.6.3 Novartis Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Novo Nordisk
13.7.1 Novo Nordisk Company Information
13.7.2 Novo Nordisk Subcutaneous Medicine Delivery Devices Product Offered
13.7.3 Novo Nordisk Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Novo Nordisk Main Business Overview
13.7.5 Novo Nordisk Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Subcutaneous Medicine Delivery Devices Product Offered
13.8.3 Pfizer Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Sanofi
13.9.1 Sanofi Company Information
13.9.2 Sanofi Subcutaneous Medicine Delivery Devices Product Offered
13.9.3 Sanofi Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Sanofi Main Business Overview
13.9.5 Sanofi Latest Developments
13.10 Teva Pharmaceutical
13.10.1 Teva Pharmaceutical Company Information
13.10.2 Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Product Offered
13.10.3 Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Teva Pharmaceutical Main Business Overview
13.10.5 Teva Pharmaceutical Latest Developments
13.11 Zogenix
13.11.1 Zogenix Company Information
13.11.2 Zogenix Subcutaneous Medicine Delivery Devices Product Offered
13.11.3 Zogenix Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Zogenix Main Business Overview
13.11.5 Zogenix Latest Developments
13.12 BD
13.12.1 BD Company Information
13.12.2 BD Subcutaneous Medicine Delivery Devices Product Offered
13.12.3 BD Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 BD Main Business Overview
13.12.5 BD Latest Developments
13.13 Insulet Corporation
13.13.1 Insulet Corporation Company Information
13.13.2 Insulet Corporation Subcutaneous Medicine Delivery Devices Product Offered
13.13.3 Insulet Corporation Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Insulet Corporation Main Business Overview
13.13.5 Insulet Corporation Latest Developments
13.14 Enable Injections
13.14.1 Enable Injections Company Information
13.14.2 Enable Injections Subcutaneous Medicine Delivery Devices Product Offered
13.14.3 Enable Injections Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Enable Injections Main Business Overview
13.14.5 Enable Injections Latest Developments
13.15 West Pharmaceutical Services
13.15.1 West Pharmaceutical Services Company Information
13.15.2 West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Product Offered
13.15.3 West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 West Pharmaceutical Services Main Business Overview
13.15.5 West Pharmaceutical Services Latest Developments
13.16 Ypsomed AG
13.16.1 Ypsomed AG Company Information
13.16.2 Ypsomed AG Subcutaneous Medicine Delivery Devices Product Offered
13.16.3 Ypsomed AG Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Ypsomed AG Main Business Overview
13.16.5 Ypsomed AG Latest Developments
13.17 Elcam Medical
13.17.1 Elcam Medical Company Information
13.17.2 Elcam Medical Subcutaneous Medicine Delivery Devices Product Offered
13.17.3 Elcam Medical Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Elcam Medical Main Business Overview
13.17.5 Elcam Medical Latest Developments
13.18 Amgen
13.18.1 Amgen Company Information
13.18.2 Amgen Subcutaneous Medicine Delivery Devices Product Offered
13.18.3 Amgen Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Amgen Main Business Overview
13.18.5 Amgen Latest Developments
13.19 Wilhelm Haselmeier
13.19.1 Wilhelm Haselmeier Company Information
13.19.2 Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Product Offered
13.19.3 Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Wilhelm Haselmeier Main Business Overview
13.19.5 Wilhelm Haselmeier Latest Developments
14 Research Findings and Conclusion



★調査レポート[世界の皮下薬物投与装置市場予測 2022年-2028年] (コード:LPI22SM18343)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の皮下薬物投与装置市場予測 2022年-2028年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆